Genome Research in African American Scleroderma
Brief Description Of Study
African Americans who have scleroderma are eligible for this study. African Americans seem to have a higher risk of developing scleroderma than other populations. This research is being done to determine how variations in genes may explain this different risk. For this study, we will collect blood samples to obtain DNA and serum and collect clinical data from African American patients who have systemic sclerosis (scleroderma). We are not studying new treatments for scleroderma. There is only 1 study visit and a blood draw. As part this study, genetic information will be collected and sent to the National Institutes of Health (NIH) Genome-Wide Association Study (GWAS) repository. Personal information that could identify a patient will NOT be sent to the NIH. Information from African American patients will be compared with healthy African Americans and West Africans who are also in the study.